# MAPT Haploid H1b and the Damage of BBB in Dorsal Medulla Oblongata and Autonomic Dysfunction in PD

> **NCT05471713** · — · UNKNOWN · sponsor: **Zhujiang Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **OTHER:** Autonomic dysfunction

## Key facts

- **NCT ID:** NCT05471713
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05471713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05471713, "MAPT Haploid H1b and the Damage of BBB in Dorsal Medulla Oblongata and Autonomic Dysfunction in PD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05471713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*